Literature DB >> 3794674

Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen.

K Ishihara, J A Waters, M Pignatelli, H C Thomas.   

Abstract

Receptors for polymerised human albumin are present on the pre-S sequence of the envelope protein of HBV and on the hepatocyte membrane and are thought to be involved in uptake of the virus by hepatocytes. Using a solid phase radioimmunoassay we demonstrate binding of HBsAg to polymerised human serum albumin (pHSA) in both HBe antigen-positive and -negative patients, and this binding is linearly related to the HBsAg titre in both groups. There are probably several modes of interaction between HBsAg and pHSA. Here we show that pHSA binds to the 22,000-dalton polypeptide of HBsAg, which does not contain the pre-S sequence. This pHSA-HBsAg interaction is inhibited by physiological concentrations of human serum albumin, suggesting that the albumin known to be present in the envelop of HBsAg plays a role in this binding. The inhibition of pHSA/HBsAg interaction by native albumin suggests that this interaction is probably not an important mechanism of virus uptake during infection of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794674     DOI: 10.1002/jmv.1890210112

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  The interaction between native serum albumin and hepatitis B virus.

Authors:  X Y Lu; G B Yao; Y F Tian
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.

Authors:  B Bucher; P Francioli; B Geudelin; B Fritzell; D Lavanchy; P C Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

Review 3.  Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.

Authors:  Qiushi Liu; Masaharu Somiya; Shun'ichi Kuroda
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.